|

anito-cel Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CART-ddBCMA, anitocabtagene autoleucel

Pipeline

Phase 1: 1

Top Sponsors

  • Arcellx, Inc.1

Indications

  • Autoimmune1
  • Muscular Diseases1
  • Neuromuscular Manifestations1
  • Autoimmune Diseases of the Nervous System1
  • Muscle Weakness1

Los Angeles, California1 trial

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

UCLA Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.